Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

Green biotechnology for valorisation of residual biomasses in nutraceutic sector: Characterization and extraction of bioactive compounds from grape pomace and evaluation of the protective effects in vitro.

Messina CM, Manuguerra S, Catalano G, Arena R, Cocchi M, Morghese M, Montenegro L, Santulli A.

Nat Prod Res. 2019 Jun 6:1-6. doi: 10.1080/14786419.2019.1619727. [Epub ahead of print]

PMID:
31170811
2.

Neuroprotective effects of Rosmarinus officinalis L. extract in oxygen glucose deprivation (OGD)-injured human neural-like cells.

Zappalà A, Vicario N, Calabrese G, Turnaturi R, Pasquinucci L, Montenegro L, Spadaro A, Parenti R, Parenti C.

Nat Prod Res. 2019 Apr 2:1-7. doi: 10.1080/14786419.2019.1587428. [Epub ahead of print]

PMID:
30938188
3.

(2S)-N-2-methoxy-2-phenylethyl-6,7-benzomorphan compound (2S-LP2): Discovery of a biased mu/delta opioid receptor agonist.

Pasquinucci L, Turnaturi R, Calò G, Pappalardo F, Ferrari F, Russo G, Arena E, Montenegro L, Chiechio S, Prezzavento O, Parenti C.

Eur J Med Chem. 2019 Apr 15;168:189-198. doi: 10.1016/j.ejmech.2019.02.043. Epub 2019 Feb 18.

PMID:
30822708
4.

Simultaneous targeting of MOR/DOR: A useful strategy for inflammatory pain modulation.

Pasquinucci L, Turnaturi R, Montenegro L, Caraci F, Chiechio S, Parenti C.

Eur J Pharmacol. 2019 Mar 15;847:97-102. doi: 10.1016/j.ejphar.2019.01.031. Epub 2019 Jan 25.

PMID:
30690004
5.

Solid Lipid Nanoparticles Loading Idebenone Ester with Pyroglutamic Acid: In Vitro Antioxidant Activity and In Vivo Topical Efficacy.

Montenegro L, Panico AM, Santagati LM, Siciliano EA, Intagliata S, Modica MN.

Nanomaterials (Basel). 2018 Dec 29;9(1). pii: E43. doi: 10.3390/nano9010043.

6.
7.

Benzomorphan skeleton, a versatile scaffold for different targets: A comprehensive review.

Turnaturi R, Montenegro L, Marrazzo A, Parenti R, Pasquinucci L, Parenti C.

Eur J Med Chem. 2018 Jul 15;155:492-502. doi: 10.1016/j.ejmech.2018.06.017. Epub 2018 Jun 7. Review.

PMID:
29908442
8.

Synthesis and Structure-Activity Relationships of (-)-cis-N-Normetazocine-Based LP1 Derivatives.

Pasquinucci L, Parenti C, Amata E, Georgoussi Z, Pallaki P, Camarda V, Calò G, Arena E, Montenegro L, Turnaturi R.

Pharmaceuticals (Basel). 2018 May 5;11(2). pii: E40. doi: 10.3390/ph11020040.

9.

In Vitro Evaluation of Sunscreen Safety: Effects of the Vehicle and Repeated Applications on Skin Permeation from Topical Formulations.

Montenegro L, Turnaturi R, Parenti C, Pasquinucci L.

Pharmaceutics. 2018 Feb 27;10(1). pii: E27. doi: 10.3390/pharmaceutics10010027.

10.

Idebenone: Novel Strategies to Improve Its Systemic and Local Efficacy.

Montenegro L, Turnaturi R, Parenti C, Pasquinucci L.

Nanomaterials (Basel). 2018 Feb 5;8(2). pii: E87. doi: 10.3390/nano8020087. Review.

11.

Resveratrol-Loaded Lipid Nanocarriers: Correlation between In Vitro Occlusion Factor and In Vivo Skin Hydrating Effect.

Montenegro L, Parenti C, Turnaturi R, Pasquinucci L.

Pharmaceutics. 2017 Dec 10;9(4). pii: E58. doi: 10.3390/pharmaceutics9040058.

12.

Rosemary Essential Oil-Loaded Lipid Nanoparticles: In Vivo Topical Activity from Gel Vehicles.

Montenegro L, Pasquinucci L, Zappalà A, Chiechio S, Turnaturi R, Parenti C.

Pharmaceutics. 2017 Oct 21;9(4). pii: E48. doi: 10.3390/pharmaceutics9040048.

13.

In Vitro Antioxidant Activity of Idebenone Derivative-Loaded Solid Lipid Nanoparticles.

Montenegro L, Modica MN, Salerno L, Panico AM, Crascì L, Puglisi G, Romeo G.

Molecules. 2017 May 27;22(6). pii: E887. doi: 10.3390/molecules22060887.

14.

Lipid-Based Nanoparticles as Carriers for Dermal Delivery of Antioxidants.

Lucia M.

Curr Drug Metab. 2017;18(5):469-480. doi: 10.2174/1389200218666170222152038. Review.

PMID:
28228079
15.

May the assessment of baseline mucosal molecular pattern predict the development of gluten related disorders among microscopic enteritis?

Losurdo G, Giorgio F, Piscitelli D, Montenegro L, Covelli C, Fiore MG, Giangaspero A, Iannone A, Principi M, Amoruso A, Barone M, Di Leo A, Ierardi E.

World J Gastroenterol. 2016 Sep 21;22(35):8017-25. doi: 10.3748/wjg.v22.i35.8017.

16.

Mucosal molecular pattern of tissue transglutaminase and interferon gamma in suspected seronegative celiac disease at marsh 1 and 0 stages.

Ierardi E, Amoruso A, Giorgio F, Principi M, Losurdo G, Piscitelli D, Buffelli F, Fiore MG, Mongelli A, Castellaneta NM, Giangaspero A, De Francesco V, Montenegro L, Di Leo A.

Saudi J Gastroenterol. 2015 Nov-Dec;21(6):379-85. doi: 10.4103/1319-3767.167189.

17.

Endothelial function and cardiovascular risk in patients with inflammatory bowel disease in remission phase.

Principi M, Montenegro L, Losurdo G, Zito A, Devito F, Bulzis G, Carbonara R, Ierardi E, Di Leo A, Ciccone MM.

Scand J Gastroenterol. 2016;51(2):253-5. doi: 10.3109/00365521.2015.1070901. Epub 2015 Jul 25. No abstract available.

PMID:
26212627
18.

Evolution of nonspecific duodenal lymphocytosis over 2 years of follow-up.

Losurdo G, Piscitelli D, Giangaspero A, Principi M, Buffelli F, Giorgio F, Montenegro L, Sorrentino C, Amoruso A, Ierardi E, Di Leo A.

World J Gastroenterol. 2015 Jun 28;21(24):7545-52. doi: 10.3748/wjg.v21.i24.7545.

19.

Seronegative celiac disease: where is the specific setting?

Ierardi E, Losurdo G, Piscitelli D, Giorgio F, Sorrentino C, Principi M, Montenegro L, Amoruso A, Di Leo A.

Gastroenterol Hepatol Bed Bench. 2015 Spring;8(2):110-6. Review.

20.

Reversal of IgM deficiency following a gluten-free diet in seronegative celiac disease.

Montenegro L, Piscitelli D, Giorgio F, Covelli C, Fiore MG, Losurdo G, Iannone A, Ierardi E, Di Leo A, Principi M.

World J Gastroenterol. 2014 Dec 14;20(46):17686-9. doi: 10.3748/wjg.v20.i46.17686.

Supplemental Content

Loading ...
Support Center